Results 161 to 170 of about 1,805,228 (296)
Predictive Value of Composite Inflammatory Markers for Stroke Prognosis: A Prospective Cohort Study
ABSTRACT Background Novel composite inflammatory markers' role in stroke prognosis is understudied, and the best predictor is unclear, requiring further exploration. Objectives This study aimed to systematically evaluate the associations of 6 novel composite inflammatory markers on stroke prognosis.
Bing Wu +7 more
wiley +1 more source
A retrospective view of medical specialty choice
H, Kritzer, C N, Zimet
openaire +3 more sources
Deep Learning Pose Estimation for Phenotyping of Co‐Occurring Hyperkinetic Movement Disorders
ABSTRACT Objective To explore whether routine outpatient video combined with deep learning‐based pose estimation and clinically interpretable kinematic features can support multi‐label phenotyping of co‐occurring hyperkinetic movement disorders (HMDs).
Laura Cif +17 more
wiley +1 more source
Family Medicine Specialty Choice at Matriculation and Graduation. [PDF]
Westfall JM, Fernald DH, Kamerow DB.
europepmc +1 more source
ABSTRACT Objective Treatment of disorders of consciousness (DoC) remains a major clinical challenge, and noninvasive, targeted modulation of deep brain structures has emerged as a promising therapeutic strategy. We aimed to evaluate the feasibility/safety and preliminary effects of thalamic temporal interference stimulation (TIS) targeting centromedian‐
Gengyao Hu +7 more
wiley +1 more source
Factors Influencing Medical Students' Specialty Choice: Insights to Address the Evolving Primary Care Gap. [PDF]
Angeli A, Ryan J, Palacios C, Al-Eyd G.
europepmc +1 more source
Factors influencing specialty choice and the effect of recall bias on findings from Irish medical graduates: a cross-sectional, longitudinal study. [PDF]
Cronin FM +4 more
europepmc +1 more source
Mary Choice (formerly Sullivan) is interviewed by Edward Clark Smith on March 21, 1987 as part of the Western North Carolina Tomorrow Black Oral History Project.
Smith, Edward Clark;
core
ABSTRACT Objective To describe long‐term outcomes after anti‐CD20 discontinuation in selected patients with secondary progressive multiple sclerosis (SPMS) who remained without subsequent disease‐modifying therapy (DMT). Methods We retrospectively analyzed data from four centers in Austria and Switzerland.
Ferdinand Otto +12 more
wiley +1 more source

